Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-632-7 | CAS number: 108-95-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Carcinogenicity
Administrative data
Description of key information
1) Phenol is not considered to be a carcinogen in experimental animals after repeated oral exposure (compare also with EU-RAR, 2006).
2) In most studies in experimental animals phenol has no carcinogenic activity after repeated dermal exposure. Only benign skin tumors were found after repeated dermal application of phenol concentrations inducing severe skin lesion due to the corrosive properties.
3) There is evidence for promoting activity of phenol after repeated dermal application at concentrations inducing severe local effects due to the corrosive properties.
4) There is no evidence for carcinogenicity in epidemiology.
Key value for chemical safety assessment
Justification for classification or non-classification
The available data indicated that classification for carcinogenicity is not warranted.
Additional information
CARCINOGENICITY IN EXPERIMENTAL ANIMALS
This endpoint is presented in Section 4.1.2.8 of the EU-RAR (2006; page 126). In the EU-RAR it was concluded that phenol is considered not to be a carcinogen in animals.
- Long-term oral studies in mice and rats (NIH, 1980; see robust study summaries in IUCLID Section 7.7)
Male and female B6C3F1 mice were exposed to 0, 2500 or 5000 ppm phenol in the drinking water (ca. 280 and 370 mg/kg bw/day). In low and high dose groups the body weight was reduced and water consumption was suppressed to 75% and 50-60% of control value, respectively. Histopathology revealed no treatment related non-neoplastic and neoplastic. Phenol was not toxic or carcinogenic for male or female B6C3F1 mice.
Male and female F344 rats exposed to the same concentrations in the drinking water ingested ca. 200 and 450 mg/kg bw/day, respectively. In both treatment groups the water consumption was decreased (80% and 90% of control value, respectively) and in the high dose groups the body weight was reduced. No treatment related effects were detected in histopathological evaluation of non-neoplastic effects. The incidence of leukaemia or lymphomas, adrenal pheochromocytomas, thyroid c-cell carcinomas (not significant when combined with c-cell adenomas), and interstitial cell tumours of the testes (high spontaneous rate) was significantly increased only in male rats that received 2,500 ppm phenol, no such effect could be observed in the high dose males. The lack of increased tumour incidences in the high dose group and the statistical analyses indicate that the increased neoplastic incidences in males of the low dose group is not considered by the authors to be associated with the administration of phenol. No increased tumour incidences were found in female rats. It is concluded that phenol was not carcinogenic for male or female F344 rats.
- Dermal exposure
In the study of Boutwell & Bosch (1959, see robust study summary in IUCLID Section 7.7) mice received twice weekly 1 drop of 10% phenol in benzene (known carcinogen) on the skin; increased tumour incidences were observed. However, the study is insufficient for evaluation of carcinogenic effects of phenol after dermal exposure using benzene as vehicle.
Medium-term dermal treatment (20 weeks) of phenol (3 mg/mouse in 200 µl acetone, twice weekly) in FVB/N wildtype mice or its transgenic mouse line TG.AC carrying a v-Ha-ras gene revealed no increase of skin tumours in wildtype or transgenic mice (but inhibition of hair growth and chronic skin irritation) (Spalding et al., 1993 and Tennant et al., 1995, see IUCLID Section 7.7 or EU-RAR 2006, page 127).
No tumours were detected in 20 mice after weekly dermal application of 100 µl 5% phenol in acetone (5 mg phenol/application; local effects but not clearly specified; same skin area exposed every 2nd week) for 32 weeks. Using the same exposure duration of 32 weeks but 25µl 20% phenol (also 5 mg/application; corrosive effects; same skin area treated every 4th week) 7 out of 18 mice showed papillomas but not carcinomas (Salaman & Glendenning, 1957, cited in MAK, 1998, see additional information in IUCLID Section 7.7).
- Promoting activity of phenol
In the study of VanDuuren et al. (1968, see detailed documentation in IUCLID Section 7.7) 20 female ICR/Ha Swiss mice per group received 14 d after initiation with 150 µg 7,12 -dimethylbenz(a)anthracene in 0.1 ml acetone (single dermal exposure) thrice weekly dermal applications of 3 mg phenol in 0.1 ml acetone for 1 year or only the solvent acetone (control). A slight increase in papillomas (cumulative incidence: 4/20; carcinomas 1/20) was detected which is not considered to be of toxicological relevance compared with controls (2/20 papillomas and 1/20 carcinoma). In this study phenol has no promoting activity after dermal exposure.
Boutwell & Bosch (1959, see detailed documentation in IUCLID Section 7.7) reported promoting experiments in mice which were not considered to be usable for evaluation of promoting activity since benzene (known carcinogen) was used as vehicle. However, in further experiments reported in this study acetone was used as vehicle for initiator and promoter (not carcinogenic like benzene). 20-24 female mice of unknown strain were initiated with 75µg DMBA/mouse; for promoting 10 or 20% phenol were used which resulted in severe local effects and promoting activity. No such effects were found with the vehicle control (DMBA treated). In summary, there is evidence for promoting activity of phenol at concentrations inducing severe local effects due to the corrosive properties.
In skin promoting experiments Salaman & Glendenning (1957, cited in MAK, 1998) treated 20 mice with 0.3 mg dimethylbenz[a]anthracene in acetone for initiation followed by weekly dermal application of 5% (local effects but not clearly specified) or 20% (corrosive effects) phenol in acetone; the same skin area was exposed every 4th week (20% phenol) or every 2nd week (5%). Dose dependent increase in tumour incidences was reported. However, no data are available on DMBA control without subsequent phenol treatment.
EPIDEMIOLOGY
In the EU-RAR (2006, page 127) only the study of Kauppinen et al. (1986; see IUCLID Section 7.10.2) was documented; it was noted that the relative risk of phenol was confounded by exposure to pesticides. When workers exposed to phenol and pesticides were excluded, the odd ratios decreased to a non-significant level. There are no further data revealing an association of phenol exposure to increased tumour rates in humans. As mentioned above no firm conclusion on risk levels could be drawn from the available data due to shortcomings like co-exposure to other chemicals (Kauppinen et al., 1993; Blair et al., 1990; Dosemeci et al., 1991), or the studies gave no significant increase in the tumour incidences (Pottern et al., 1992)(studies cited in MAK, 1998; see also IUCLID Section 7.10.2).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.